RecruitingPhase 2NCT07589595
A Study of Donanemab (LY3002813) in Participants With Early Cognitive Decline (TRAILBLAZER-ALZ 7)
Sponsor: Eli Lilly and Company
Englewood, CO · +41 more sites
2 recruiting alzheimer's disease studies with a site in Englewood, CO.
All trials in Englewood, CO · All Alzheimer's Disease trials
Sponsor: Eli Lilly and Company
Englewood, CO · +41 more sites
Sponsor: Lighthouse Pharmaceuticals, Inc.
Englewood, CO · +38 more sites
Listings come from ClinicalTrials.gov and are provided for information only. Always confirm eligibility with the study team and talk with your doctor before making decisions about your care.